Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.
Stereotaxis CEO David Fischel says the MAGiC catheter was designed "to overcome the natural limitations of manual pull-wire ...
In patients undergoing chronic total occlusion (CTO) percutaneous coronary intervention (PCI), stenting demonstrated improved long-term survival and fewer cardiac arrests at one year. The ...
Stereotaxis’ CEO said the company has been “hampered clinically, commercially and strategically” by its prior dependence on a ...
Six advanced cardiac procedures were carried out for the first time in Egypt’s Aswan governorate without open-heart surgery, ...
Performing PCI on a chronic total occlusion (CTO), or in fact doing any type of transcatheter intervention, is associated with a significant stress response for the interventional cardiologist beyond ...
ATLANTA, GA (May 20, 2022) – A new analysis of PROGRESS-CTO (PROspective Global REgiStry for the Study of Chronic Total Occlusion Intervention; www.progresscto.org), an international multi-center ...
The chance of surviving a cardiac arrest varies widely across hospitals in the United States, even when the arrest occurs in the highly controlled setting of a cardiac catheterization lab, a new study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback